Convalescent plasma misses the mark in phase 2 trial
AstraZeneca Gets FDA Nod To Resume US Covid-19 Trial
AstraZeneca, Oxford allowed to resume Covid-19 vaccine trial in U.S. – WSJ
Foghorn hits Nasdaq in $120M debut as the biotech IPO boom shows no sign of slowing
Blood of recovered Covid-19 patients shows little benefit as treatment
Gilead’s Remdesivir Wins FDA’s First COVID-19 Drug Approval
Data hackathon analyses truth behind TB vaccine and COVID-19
FDA Grants Full Approval to Remdesivir for Covid-19
From the Bench to Benchling
Sarah Nicole Forrester, Ann Moormann awarded $2 million NCI SeroNet grant
A tiny circular racetrack for light can rapidly detect single molecules
Futures Slide Ahead Of Final Debate, On Lack Of "Stimulus Optimism"
AstraZeneca Covid-19 Brazil Trial To Continue After Volunteer Dies - Report
Coronavirus vaccine trials won't tell us if they save lives, prevent serious illness or stop transmission – here's why
Patient In AstraZeneca COVID-19 Vaccine Trial Dies
AZ’s COVID-19 vaccine trial ready to resume in US – reports
Pfizer, BioNTech start combined trials of Covid-19 vaccine candidate in Japan
Ireland Imposes New Fines For Violating Europe's Most Restrictive Lockdown: Live Updates
Moderna CEO expects Covid-19 vaccine interim results in November – WSJ
India Reports Fewest COVID-19 Cases In 3 Months; Argentina 5th Country To Top 5 Million Cases: Live Updates
These 3 Penny Stocks Have Massive Upside Potential, Says Cowen
Wisconsin Judge Reinstates COVID-19 Restrictions On Restaurants, Bars: Live Updates
Goldman Sachs: 2 Stocks That Could Climb Over 90%
Viral ‘molecular scissor’ is next COVID-19 drug target
US Close – Stocks bounce back on sales and sentiment data, Oil choppy on Libya concerns, Gold remains stuck
Fujifilm seeks approval for Avigan as Covid-19 treatment in Japan
FDA officials, experts discuss impact of Covid-19 on cell and gene therapies
After years of shortages, Merck announces plans for a new factory for an old lifesaving drug
NIH begins large clinical trial to test immune modulators for treatment of COVID-19
Rare diseases, repurposing and the role of AI